Ambrx Biopharma Inc.·4

Jun 9, 4:11 PM ET

Chang Xiaowei 4

4 · Ambrx Biopharma Inc. · Filed Jun 9, 2023

Insider Transaction Report

Form 4
Period: 2023-06-07
Transactions
  • Award

    Cash-Settled RSU's

    2023-06-0785,00085,000 total
    Ordinary Shares (85,000 underlying)
  • Award

    Cash-Settled RSU's

    2023-06-07125,000125,000 total
    Ordinary Shares (125,000 underlying)
Footnotes (3)
  • [F1]Represents grant of Restricted Stock Units (the "RSUs") payable solely in cash based on the market price of the underlying Ordinary Shares on the vesting date (the reporting person will never receive the Ordinary Shares).
  • [F2]The RSUs vest on the earlier of (i) the one year anniversary of the date of grant and (ii) the day before the next annual general meeting.
  • [F3]The RSUs vest in three (3) successive equal annual installments following June 8, 2023.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION